Liquid Biopsy Research Tools, Services and Diagnostics: Global Market Analysis & Outlook Through 2017-2018 and 2019-2023

Donnerstag, 28. März 2019 10:52

Dublin, March 28, 2019 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents, and companies. The market sizes for liquid biopsy diagnostics are given for 2017, 2018 and 2023 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. The report then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Key forces driving the market are enumerated.

The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2017 through November 2018. Industry subsectors analyzed include advanced sequencing instruments; droplet digital PCR (polymerase chain reaction); target enrichment; single-cell DNA polymerase; non-invasive prenatal testing (NIPT); fetal-cell NIPT; CTC (circulating tumor cell) capture and detection; and liquid biopsy.

The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics, and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring), and geography (North America, Europe, Asia/Pacific, Rest of World).

Market data covers 2017, 2018 and 2023 (forecasted).

More than 175 companies in the liquid biopsy industry are profiled in this report.

The publisher provides a summary of the main industry acquisitions and strategic alliances from January 2017 through November 2018, including key alliance trends.

The report includes:

  • 32 data tables and 54 additional tables
  • Industry analysis of the liquid biopsy biomarkers and technologies market
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Characterization and quantification of market potential for liquid biopsy diagnostics by application, biomarker type, analysis platform, analysis purpose, and geographical region
  • Discussion of several significant large-scale research initiatives that are contributing to liquid biopsy market development
  • Examination of various conventional biopsy methods and highlight how liquid biopsy enabling technologies address the issues and are gaining significant traction with key opinion leaders
  • Coverage of significant patents and their allotments in each category, as well as major industry acquisitions and strategic alliances data
  • Company profiles of major manufacturers and suppliers of liquid biopsy research tools, services, and diagnostics, including Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, Qiagen, Quantum Biosystems, Roche and Thermo Fisher Scientific

Key Topics Covered

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

Chapter 2 Summary

Chapter 3 Overview

  • Introduction
  • Report Scope
  • Liquid Biopsy Versus Traditional Biopsy
  • Markets
  • Forces Driving Growth
  • Key Trends
  • Industry

Chapter 4 Technology Background

  • Liquid Biopsy Biomarkers
  • Cancer Genomics
  • Non-Invasive Prenatal Testing
  • Circulating Tumor Cell Technologies
  • CTC Workflow
  • Cell Isolation Technologies
  • CTC Sample Preparation Technologies
  • CTC Downstream Analysis Technologies
  • Comparison of Liquid Biopsy with Conventional Biopsy
  • Cancer Testing
  • Prenatal Testing

Chapter 5 Liquid Biopsy Initiatives

  • Blood Profiling Atlas
  • Cancer-ID
  • CTC Trap Consortium
  • Early Cancer Detection Consortium
  • EpiFemCare
  • Human Cell Atlas
  • Immunomonitor Consortium
  • Integration of Imaging and Fluid-based Tumor Monitoring in Cancer Therapy Program
  • Liquid Biopsies and Imaging for Improved Cancer Care
  • Next-Generation Single-Cell Analysis Program
  • Population Sequencing Projects
  • Precancer Atlas
  • Precision Medicine Initiative
  • Single-Cell Proteomics and Lipidomics Project
  • TopMed
  • Worldwide Innovative Networking (WIN) Consortium
  • Single-Cell Research
  • Cambridge Single-Cell Analysis Core Facility
  • Harvard Medical School Single-Cell Core
  • Mayo Medical Genome Facility
  • National Center for Single-Cell Biology
  • Single-Cell Analysis Core
  • UC San Francisco Single-Cell Analysis Center

Chapter 6 Market Breakdown by End User

  • Introduction
  • Cancer Applications
  • Precision Medicine
  • Cancer Biomarker Status
  • Cancer Market Segments
  • Reproductive Health Applications
  • Transplant Diagnostics Applications

Chapter 7 Liquid Biopsy Industry

  • Advanced Sequencing Instruments Industry
  • Droplet Digital PCR Industry
  • Target Enrichment and Amplification Industry
  • Single-Cell DNA Polymerase Industry
  • Non-Invasive Prenatal Testing Industry
  • Fetal Cell NIPT Industry
  • CTC Capture and Detection Industry
  • Liquid Biopsy Assay Industry

Chapter 8 Industry Acquisitions and Strategic Alliances

  • Acquisitions
  • Strategic Alliances
  • Key Trends
  • 2017 Alliances
  • 2018 Alliances

Chapter 9 Liquid Biopsy Markets

  • Forces Driving Growth
  • Liquid Biopsy Market by Indication
  • Liquid Biopsy Market by Biomarker Type
  • Liquid Biopsy Market by Analysis Platform
  • Liquid Biopsy Market by Analysis Purpose
  • Non-Invasive Prenatal Testing Market
  • Cancer Markets
  • Cancer Market by Indication
  • Cancer Market by Analysis Purpose
  • Cancer Market by Biomarker Class
  • Cancer Market by Analysis Method
  • Breast Cancer Market
  • Colorectal Cancer Market
  • Hematological Cancer Market
  • Lung Cancer Market
  • Pan-cancer Market
  • Transplant Markets
  • Regional Market Analysis

Chapter 10 Patent Review/ New Developments

  • Circulating Tumor Cell Patents
  • Exosome Patents
  • Cell-free DNA Patents
  • Liquid Biopsy and Sequencing-related Patent Issues

Chapter 11 Company Profiles

  • Accuragen, Inc.
  • Adaptive Biotechnologies Inc.
  • Advanced Cell Diagnostics Inc.
  • Agilent Technologies Inc.
  • Akadeum Life Sciences
  • Alcediag
  • Amoy Diagnostics Co. Ltd.
  • Angle Plc
  • Apocell Inc.
  • Apostle Inc.
  • Arcedi Biotech Aps
  • Arup Laboratories
  • Asuragen Inc.
  • Atreca Inc.
  • Aviva Biosciences
  • Baylor Genetics
  • Becton, Dickinson And Co.
  • Bellwether Bio Inc.
  • Berry Genomics Co. Ltd.
  • Bgi Shenzhen
  • Biocartis Nv
  • Biocept Inc.
  • Biocore Co. Ltd.
  • Biodesix Inc.
  • Biofluidica Inc.
  • Biogazelle
  • Biomarx Inc.
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Ltd.
  • Biovendor-Laboratorni Medicina A.S.
  • Bluestar Genomics Inc.
  • Boreal Genomics
  • Cancer Genetics Inc.
  • Caredx Inc.
  • Cegat Gmbh
  • Cellmax Life
  • Cell Microsystems Inc.
  • Celsee Diagnostics
  • Chronix Biomedical
  • Circulogene Theranostics
  • Circulomics Inc.
  • Clinical Genomics Technologies
  • Codiak Biosciences
  • Color Genomics
  • CS Genetics Ltd.
  • Cygnus Biosciences Co. Ltd.
  • Cynvenio Biosystems Inc.
  • Cytotrack Aps
  • Datar Cancer Genetics Ltd.
  • Diacarta Inc.
  • Diagnologix Llc
  • Diagnomics
  • Direct Genomics Co. Ltd.
  • DNA Electronics Ltd.
  • Dnalytics
  • Dnanexus Inc.
  • Dovetail Genomics Llc
  • Envision Genomics
  • Epic Sciences Inc.
  • Eurofins Scientific
  • Exact Sciences Corp.
  • Exosome Sciences Inc.
  • Expedeon Ag
  • Ezlife Bio Inc.
  • Fabric Genomics
  • Fluxion Biosciences Inc.
  • Freenome Inc.
  • Genapsys Inc.
  • Genedx Inc.
  • Geneseq Biosciences Pty Ltd.
  • Genetics Research Llc
  • Genomatix Gmbh
  • Genomic Health Inc.
  • Genomoncology
  • Genospace
  • Genexosome Technologies Inc.
  • Gigagen Inc.
  • Golden Helix
  • Grail Inc.
  • Guardant Health Inc.
  • Helitec
  • Helix Opco Llc
  • HTG Molecular Diagnostics Inc.
  • Illumina Inc.
  • Immunovia Ab
  • Inex Innovations Exchange Pte. Ltd.
  • Inivata Ltd.
  • Interpace Diagnostics Llc
  • Invitae Inc.
  • Invivoscribe Inc.
  • JBS Science Inc.
  • Koninklijke Philips N.V.
  • Laboratory Corp. Of America Inc.
  • Lexent Bio Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Mammoth Biosciences Inc.
  • Mdna Life Sciences Inc.
  • Mdxhealth Inc.
  • Medgenome Labs Pvt. Ltd.
  • Medomics Llc
  • Menarini Silicon Biosystems Spa
  • Merck Kgaa
  • Molecular Health Gmbh
  • Myriad Genetics Inc.
  • Namocell Inc.
  • Nanostring Technologies Inc.
  • Nanoview Biosciences Inc.
  • Natera Inc.
  • Naveris Inc.
  • Neogenomics Laboratories
  • New England Biolabs
  • New Oncology Gmbh
  • Nipd Genetics
  • N-Of-One Inc.
  • Novogene Co. Ltd.
  • Nugen Technologies Inc.
  • Nuprobe Inc.
  • NX Prenatal Inc.
  • Oncocyte Corp.
  • Oncodna S.A.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California Inc.
  • Pangaea Oncology
  • Paradigm Diagnostics Inc.
  • Parseq Lab Co. Ltd.
  • Pathway Genomics Corp.
  • Personal Genome Diagnostics Inc.
  • Pieriandx
  • Portable Genomics Llc
  • Precipio Inc.
  • Predicine Inc.
  • Premaitha Health Plc
  • Prenetics
  • Provista Diagnostics Inc.
  • Qiagen Nv
  • Quantapore Inc.
  • Quantum Biosystems Inc.
  • Quantumdx
  • Quest Diagnostics Inc.
  • Rarecells Sas
  • Rarecyte Inc.
  • Real Time Genomics Inc.
  • Resolution Bioscience Inc.
  • Roche Holding Ag
  • Screencell
  • Seekin
  • Sengenics Ltd.
  • Sequencing.Com
  • Seven Bridges Genomics Inc.
  • Singlera Genomics Inc.
  • Sophia Genetics
  • Spera Medical
  • Sphere Fluidics Ltd.
  • Stilla Technologies
  • Strand Life Sciences Pvt. Ltd.
  • Stratos Genomics Inc.
  • Syapse
  • Sysmex Inostics Gmbh
  • Tai Diagnostics Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Thorne Diagnostics Inc.
  • Transplant Genomics
  • Trovagene Inc.
  • Twinstrand Biosciences
  • Two Pore Guys Inc.
  • Tymora Analytical Operations Llc
  • Ubiquity Genomics Inc.
  • Vortex Biosciences
  • Xing Technologies Llc
  • Vela Diagnostics
  • Volitionrx
  • Vortex Biosciences
  • Yikon Genomics Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/qlpdbd/liquid_biopsy?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics

22157.jpg

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.